MAP2K4 抗体
Quick Overview for MAP2K4 抗体 (ABIN2725392)
抗原
See all MAP2K4 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
- 
    - 
                                            纯化方法
- Purified from mouse ascites fluids by affinity chromatography
- 
                                            免疫原
- Full-length protein expressed in 293T cell transfected with human MAP2K4 expression vector
- 
                                            亚型
- IgG1
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- WB 1:2000, IHC 1:150, IF 1:100, IP 2 μg/500 μL
- 
                                            说明
- 
                        The concentration of the product may vary between diferrent lots. 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- 0.5-1.0 mg/mL
- 
                                            缓冲液
- PBS ( pH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 
- 
                                            
- 
    - MAP2K4 (Mitogen-Activated Protein Kinase Kinase 4 (MAP2K4))
- 
                                            别名
- MAP2K4
- 
                                            分子量
- 44.3 kDa
- 
                                            基因ID
- 6416
- 
                                            NCBI登录号
- NM_003010
- 
                                            HGNC
- 6416
- 
                                            途径
- MAPK Pathway, TLR signaling, Fc-epsilon Receptor Signaling Pathway, Activation of Innate immune Response, Toll-Like Receptors Cascades, BCR Signaling
 抗原
- 
                    
 
                                     
                                     
                                    